Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial–mesenchymal transition programme under hypoxia
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
A wide range of genes involved in breast cancer metastasis have been reported to be related to the microenvironment. We studied the role of discoidin domain receptor 2 (DDR2), a collagen‐binding receptor, in breast cancer progression under hypoxic conditions. We showed that DDR2 protein expression closely correlated with the expression of hypoxic marker HIF‐1α in clinical breast cancer specimens. The in vitro data demonstrated that hypoxia treatment increased the levels of both expression and phosphorylation of DDR2 in human breast cancer cell lines. In vivo, orthotopic breast tumour xenografts with DDR2 knockdown displayed reduced dissemination and significant prevention in pulmonary and lymphatic metastasis; conversely, these processes were significantly facilitated by the enforced expression of the activated form of DDR2. Further mechanism studies indicated that DDR2 plays an indispensable role in a series of hypoxia‐induced behaviours of breast cancer cells, including migration, invasion, and epithelial–mesenchymal transition (EMT). The transcription factor Snail was found to mediate DDR2‐induced down‐regulation of the cell–cell adhesion molecule E‐cadherin. It was also documented that there is a correlation between DDR2 and E‐cadherin expression with the presence of lymph node metastases in 160 cases of invasive human breast carcinoma. In addition, we provided evidence that DDR2 silencing in breast cancer cells prevents the hypoxia‐induced activation of ERK MAPK, suggesting its potential involvement in mediating the effect of DDR2 on hypoxia‐induced signalling. Based on the results of this study, we conclude that DDR2 participates in hypoxia‐induced breast cancer metastasis through the regulation of cell migration, invasion, and EMT, and thus may serve as an accessible therapeutic target for the treatment of breast cancer.Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719 · cited 1×
“As the repression of E-cadherin transcription can be achieved through direct binding of Snail to the E-box present in its promoter, and the mutation of the E-box element can impair Snail-mediated repression [26], we examined the regulatory effects of DDR2 on the E-cadherin promoter with and without a functional E-box.”
BackgroundThe Discoidin Domain Receptor Tyrosine Kinases Are Activated by Collagen
Vogel, W., Gish, G. D., Alves, F., & Pawson, T. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80003-9 · Cited by 1,002 · cited 4×
“In view of the fact that activation of DDR2 was sustained over a period of 18 h [8], we examined the long-term effects of hypoxia on DDR2 phosphorylation.”
BackgroundInfluentialHIF-1 and HIF-2 Transcription Factors - Similar but Not Identical
Loboda, A., Jozkowicz, A., & Dulak, J. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0067-2 · Cited by 477
Olaso, E., Labrador, J.-P., Wang, L., Ikeda, K., Eng, F. J., Klein, R., Lovett, D. H., Lin, H. C., & Friedman, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107571200 · Cited by 238 · cited 1×
“It is generally accepted that DDR2 promotes cell proliferation [15,35,36].”
Background
Cited by
Non-redundant functions of EMT transcription factors
Stemmler, M. P., Eccles, R. L., Brabletz, S., & Brabletz, T. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0196-y · Cited by 524
Olivares, O., Mayers, J. R., Gouirand, V., Torrence, M. E., Gicquel, T., Borge, L., Lac, S., Roques, J., Lavaut, M.-N., Berthezène, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms16031 · Cited by 413
Emerging roles of ECM remodeling processes in cancer
Mohan, V., Das, A., & Sagi, I. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.004 · Cited by 334
SALMON: survival analysis learning with multi-omics neural networks on breast cancer
Huang, Z., Zhan, X., Xiang, S., Johnson, T. S., Helm, B., Yu, C. Y., Zhang, J., Salama, P., Rizkalla, M., Han, Z., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00166 · Cited by 262
“Among them, DDR2 plays an indispensable role in a series of hypoxia-induced behaviors of breast cancer cells, such as migration, invasion, and epithelial-mesenchymal transition (EMT), the activated DDR2 can promote the metastasis of breast cancer (Ren et al., 2014).”
BackgroundSelf-citation
Metadata
- Authors
- Ren, T., Zhang, W., Liu, X., Zhao, H., Zhang, J., Zhang, J., Li, X., Zhang, Y., Bu, X., Shi, M., Yao, L., & Su, J.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2014-09-15
- Volume
- 234
- Issue
- 4
- Pages
- 526-537
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2127760027
- Cited by
- 79
- References
- 5
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial–mesenchymal transition programme under hypoxia. https://app.cochat.ai/papers/10.1002/path.4415
- The paper
- Ren, T., Zhang, W., Liu, X., Zhao, H., Zhang, J., Zhang, J., Li, X., Zhang, Y., Bu, X., Shi, M., Yao, L., & Su, J. (2014). Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial–mesenchymal transition programme under hypoxia. The Journal of Pathology. https://doi.org/10.1002/path.4415
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.